DK158991C - CHOLE STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES - Google Patents

CHOLE STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES

Info

Publication number
DK158991C
DK158991C DK015390A DK15390A DK158991C DK 158991 C DK158991 C DK 158991C DK 015390 A DK015390 A DK 015390A DK 15390 A DK15390 A DK 15390A DK 158991 C DK158991 C DK 158991C
Authority
DK
Denmark
Prior art keywords
derivatives
homovitamin
chole
intermediates
stage
Prior art date
Application number
DK015390A
Other languages
Danish (da)
Other versions
DK15390A (en
DK15390D0 (en
DK158991B (en
Inventor
Hector F Deluca
Nobuo Ikekawa
Yoko Tanaka
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK15390A publication Critical patent/DK15390A/en
Publication of DK15390D0 publication Critical patent/DK15390D0/en
Publication of DK158991B publication Critical patent/DK158991B/en
Application granted granted Critical
Publication of DK158991C publication Critical patent/DK158991C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK015390A 1984-10-04 1990-01-19 CHOLE STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES DK158991C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65754984A 1984-10-04 1984-10-04
US65754984 1984-10-04
PCT/US1985/001571 WO1986002078A1 (en) 1984-10-04 1985-08-19 Vitamin d derivatives and methods for preparing same
US8501571 1985-08-19

Publications (4)

Publication Number Publication Date
DK15390A DK15390A (en) 1990-01-19
DK15390D0 DK15390D0 (en) 1990-01-19
DK158991B DK158991B (en) 1990-08-13
DK158991C true DK158991C (en) 1991-01-21

Family

ID=24637652

Family Applications (5)

Application Number Title Priority Date Filing Date
DK260086A DK154290C (en) 1984-10-04 1986-06-03 VITAMIN-D DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK111188A DK159389C (en) 1984-10-04 1988-03-02 CHOLESTAGE STAGE OR TRIEND DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF 24-HOMOVITAMIN-D3 DERIVATIVES
DK177489A DK158989C (en) 1984-10-04 1989-04-13 CHOLESTA STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATE FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES
DK015290A DK158990C (en) 1984-10-04 1990-01-19 CHOLESTA STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATE FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES
DK015390A DK158991C (en) 1984-10-04 1990-01-19 CHOLE STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK260086A DK154290C (en) 1984-10-04 1986-06-03 VITAMIN-D DERIVATIVES AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE
DK111188A DK159389C (en) 1984-10-04 1988-03-02 CHOLESTAGE STAGE OR TRIEND DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF 24-HOMOVITAMIN-D3 DERIVATIVES
DK177489A DK158989C (en) 1984-10-04 1989-04-13 CHOLESTA STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATE FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES
DK015290A DK158990C (en) 1984-10-04 1990-01-19 CHOLESTA STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATE FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES

Country Status (13)

Country Link
EP (1) EP0197949A1 (en)
JP (3) JPS62500301A (en)
AU (2) AU582789B2 (en)
BE (1) BE903376A (en)
CH (1) CH672920A5 (en)
DE (2) DE3590488T (en)
DK (5) DK154290C (en)
FR (1) FR2571369B1 (en)
GB (2) GB2167070B (en)
IE (1) IE58104B1 (en)
IT (1) IT1190401B (en)
NL (1) NL8520265A (en)
WO (1) WO1986002078A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0412110B1 (en) * 1988-04-21 1993-07-07 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Novel vitamin d analogues
US4927815A (en) * 1988-04-29 1990-05-22 Wisconsin Alumni Research Foundation Compounds effective in inducing cell differentiation and process for preparing same
KR940003360B1 (en) * 1988-04-29 1994-04-21 위스콘신 알럼나이 리써취 파운데이션 Side chain unsaturated 1 alpha-hydroxyvitamin d homologs
US5063221A (en) * 1989-04-05 1991-11-05 Chugai Seiyaku Kabushiki Kaisha Treatment for hyperparathyroidism with use of vitamin d derivatives
DE3933034A1 (en) * 1989-10-02 1991-04-11 Schering Ag 24-HOMO-VITAMIN-D DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
US5891865A (en) * 1996-10-04 1999-04-06 Wisconsin Alumni Research Foundation Treatment of arthritic disease induced by infectious agents
AU2005303773A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin D derivatives and anti-proliferative agents for treating bladder cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833622A (en) * 1969-03-17 1974-09-03 Upjohn Co Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
AU527805B2 (en) * 1978-07-27 1983-03-24 Research Institute For Medicine And Chemistry Inc. 1alpha, 1beta dihydroxy steroid-5-enes
US4225596A (en) * 1978-10-13 1980-09-30 Wisconsin Alumni Research Foundation Method for treating calcium imbalance and improving calcium absorption in mammals
US4448721A (en) * 1982-09-20 1984-05-15 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 compounds and process for preparing same
US4508651A (en) * 1983-03-21 1985-04-02 Hoffmann-La Roche Inc. Synthesis of 1α,25-dihydroxyergocalciferol
CH665834A5 (en) * 1983-05-09 1988-06-15 Wisconsin Alumni Res Found METHOD FOR PRODUCING 1ALPHA, 25-DIHYDROXYLATED VITAMIN D (2) AND RELATED COMPOUNDS.

Also Published As

Publication number Publication date
DK111188A (en) 1988-03-02
DK158989B (en) 1990-08-13
DK111188D0 (en) 1988-03-02
JPH0689022B2 (en) 1994-11-09
NL8520265A (en) 1986-09-01
DK15390A (en) 1990-01-19
JPH0569103B2 (en) 1993-09-30
JPH05178887A (en) 1993-07-20
DK260086A (en) 1986-06-03
IE852443L (en) 1986-04-04
WO1986002078A1 (en) 1986-04-10
GB2167070A (en) 1986-05-21
DK260086D0 (en) 1986-06-03
JPS62500301A (en) 1987-02-05
AU582789B2 (en) 1989-04-13
DE3590488C2 (en) 1992-10-01
DK158990C (en) 1991-01-21
CH672920A5 (en) 1990-01-15
AU4776185A (en) 1986-04-17
JPH0635475B2 (en) 1994-05-11
AU605007B2 (en) 1991-01-03
DK15290A (en) 1990-01-19
DK159389C (en) 1991-03-11
GB2167070B (en) 1988-09-01
IT8522359A0 (en) 1985-10-04
DE3590488T (en) 1986-10-09
GB2188932B (en) 1988-09-01
DK177489D0 (en) 1989-04-13
DK15390D0 (en) 1990-01-19
BE903376A (en) 1986-02-03
DK158989C (en) 1991-01-21
DK154290C (en) 1989-03-28
GB2188932A (en) 1987-10-14
DK154290B (en) 1988-10-31
GB8524479D0 (en) 1985-11-06
FR2571369B1 (en) 1987-12-04
DK15290D0 (en) 1990-01-19
DK177489A (en) 1989-04-13
IT1190401B (en) 1988-02-16
DK158990B (en) 1990-08-13
AU2761488A (en) 1989-06-08
GB8709579D0 (en) 1987-05-28
EP0197949A1 (en) 1986-10-22
IE58104B1 (en) 1993-06-30
DK158991B (en) 1990-08-13
DK159389B (en) 1990-10-08
FR2571369A1 (en) 1986-04-11
JPH05222089A (en) 1993-08-31

Similar Documents

Publication Publication Date Title
DK159146C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF 1,2-DIAMINOCYCLOBUTEN-3,4-DIONE AND CYCLOBUTEN-3,4-DIONE DERIVATIVES FOR USING AS INTERMEDIATES IN THE PROCEDURE
NO842273L (en) PROCEDURE FOR THE PREPARATION OF AMINOMETHYLOXOOXAZOLIDINYL BENZEN DERIVATIVES.
NO852994L (en) PROCEDURE FOR THE PREPARATION OF GLUTARAMIDE DERIVATIVES.
DK161330C (en) OXAZOLINOAZETIDE INGREDIENTS USED AS INTERMEDIATES IN THE PREPARATION OF 1-OXADETHIACEPHALOSPORINES AND PROCEDURES FOR THE PREPARATION OF THE OXAZOLINOAZETIDE INGREDIENTS
DK184588D0 (en) INTERMEDIATES FOR USE IN THE PREPARATION OF 1ALFA, 25-DIHYDROXYLERED VITAMIN D2 DERIVATIVES
DK158991C (en) CHOLE STAGE DERIVATIVES THAT MAY BE USED AS INTERMEDIATES FOR USE IN THE PREPARATION OF HOMOVITAMIN-D3 DERIVATIVES
DK505080A (en) PROCEDURE FOR THE PREPARATION OF 24,24-DIFLUOR1ALFA, 25-DIHYDROXYCHOLECALCIFEROL AND INTERMEDIATES FOR USING THE PROCEDURE
DK108780A (en) PROCEDURE FOR THE MANUFACTURING OF URINARY DERIVATIVES, THEIR USE AND INTERMEDIATES FOR USE IN THE PREPARATION
NO160205C (en) PROCEDURE FOR THE PREPARATION OF SILIBINE INGREDIENTS.
DK162394C (en) 26-HOMOCHOLESTA-5-A COMPOUND USED AS INTERMEDIATE FOR USE IN THE PREPARATION OF 26-HOMOVITAMIN D3 DERIVATIVES
DK437287A (en) 2,3-DIHYDROFURAND DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INTERMEDIATES FOR THE PREPARATION OF TETRAHYDROFURAND DERIVATIVES
IT1198751B (en) PHTHALOCYANINS, THEIR PREPARATION AND THEIR USE AS COLORANTS
DK157865C (en) PROCEDURE FOR THE PREPARATION OF RANITIDINE AND ETHYLENIMINO DERIVATIVES FOR USE AS THE PRESENT MATERIAL OF THE PROCEDURE
DK422582A (en) OXIRANS USED AS INTERMEDIATES IN THE PREPARATION OF SUBSTITUTED 1-AZOLYL-2-HYDROXY ALKANDER DERIVATIVES
DK422382A (en) OXIRANS USED AS INTERMEDIATES IN THE PREPARATION OF SUBSTITUTED 2-HYDROXY-3-AZOLYL PROPANDER DERIVATIVES
DK513888A (en) PROCEDURE FOR THE PREPARATION OF 2- (1-HALOGENALKYL) THIAZOL COMPOUNDS AND UNKNOWN UNDERTAKINGS THAT MAY BE PREPARED BY THE PROCEDURE
DK382183A (en) IN 6-POSITION UN-SUBSTITUTED 7-OXO-4-OXA-DIAZABICYCLO (3.2.0) HEPT-2-EN DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATES FOR THE PREPARATION OF THE BIBLE PRODUCT
DK144698C (en) 2,4-DIAMINO-6-HALOGEN-5-BENZYLPYRIMIDINES USED AS INTERMEDIATES IN THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES
DK135885D0 (en) INTERMEDIATE SUITABLE FOR USE IN THE PREPARATION OF TERBUTAL INGREDIENTS
DK160987C (en) 9,10-DIHYDROXY-PERHYDROISOQUINOLINE DERIVATIVES USED AS INTERMEDIATE IN THE PREPARATION OF 14-HYDROXY-MORPHINANDER DERIVATIVES
DK158347C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF 1-ACYL-2,3-DIHYDRO-1H-INDOL-2-CARBOXYL ACID OR ITS DERIVATIVES AND INTERMEDIATES FOR USING THE PROCEDURE
DK153945C (en) ALKYL-3-ACYL-1,2,3,4,4A, 5,10,10A-OCTAHYDRO-2,5-METHANOBENZO (G) QUINOLIN-3-CARBOXYLATES USED AS INTERMEDIATES IN THE PREPARATION OF 11 (EQ) - ( 2-ACYLETHYL) -1,2,3,4,5,6-HEXAHYDRO-2,6-METHANO-3-BENZAZOCINES, AND PROCEDURE FOR PREPARING THE BENZAZOCINES
DK145718C (en) DIBROME COMPOUND USE AS INTERMEDIATE IN THE PREPARATION OF N- (2-AMINO-3,5-DIBROMBENZYL) -N-METYLCYCLOHEXYLAMINE
DK155323C (en) D, 1-6-OXO-4,5,6,7-TETRAHYDRO-1H- (OR 2H) -INDAZOL FOR INTERMEDIATE USE IN THE PREPARATION OF TAUTOMER AMINO-SUBSTITUTED 4,5,6,7-TETRAHYDRO-1H- (OR 2H) ) -INDAZOLER
DK532480A (en) 8-CARBOXAMIDO OR CYANO-11H-PYRIDO (2,1-B) -QUINAZOLINE-11-ONES USED AS INTERMEDIATES IN THE PREPARATION OF THE SIMILAR 8-TETRAZOL-5-YL COMPOUNDS